Acute heart failure with mildly reduced ejection fraction and myocardial infarction: a multi-institutional cohort

Ming-Shyan Lin1,2,3, Po-Chang Wang1, Meng-Hung Lin4

  • 1Division of Cardiology, Department of Internal Medicine, Chang Gung Memorial Hospital Chiayi Branch, Chiayi, Taiwan.

Insights

Patients with heart failure with mid-range ejection fraction (HFmrEF) face higher risks of myocardial infarction. Further large-scale research is needed to understand HFmrEF and ischemic cardiomyopathy, guiding optimal anti-ischemic treatments.

Area of Science:

  • Cardiology
  • Heart Failure Research
  • Ischemic Outcomes

Background:

  • Limited research exists on ischemic outcomes in acute decompensated heart failure (ADHF) related to left ventricular ejection fraction (EF).
  • Understanding these outcomes is crucial for managing ADHF patients.

Purpose of the Study:

  • To investigate ischemic outcomes in patients with different ranges of left ventricular ejection fraction (EF) within acute decompensated heart failure (ADHF).
  • To compare the clinical outcomes, including cardiovascular mortality and rehospitalization, among patients with heart failure with preserved ejection fraction (HFpEF), mid-range ejection fraction (HFmrEF), and reduced ejection fraction (HFrEF).

Main Methods:

  • A retrospective cohort study utilizing the Chang Gung Research Database from 2001 to 2021.
  • Inclusion of ADHF patients discharged between January 1, 2005, and December 31, 2019.
  • Primary outcomes included cardiovascular mortality and heart failure rehospitalization, with secondary outcomes of all-cause mortality, acute myocardial infarction (AMI), and stroke.

Main Results:

  • A cohort of 12,852 ADHF patients was analyzed, with 2,222 (17.3%) classified as HFmrEF.
  • HFmrEF patients exhibited a higher prevalence of comorbidities like diabetes, dyslipidemia, and ischemic heart disease compared to HFrEF and HFpEF.
  • HFmrEF patients had the highest rate of AMI (13.6%) compared to HFpEF (9.3%) and HFrEF (9.9%), indicating an increased risk.

Conclusions:

  • Acute decompensation in HFmrEF patients is associated with an elevated risk of myocardial infarction.
  • Further large-scale research is warranted to explore the relationship between HFmrEF and ischemic cardiomyopathy.
  • Optimal anti-ischemic treatment strategies for HFmrEF require additional investigation.
Abstract

Related Concept Videos

Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
21
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.7K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
26
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
17
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
28
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
16